#hypertension_vascular_health

Dizzy on Standing? Don’t Blame the Blood Pressure Pill

Medically Reviewed by Dr. Şekip Altunkan on Oct 4, 2026.
Medical illustration from Vitals Daily

Key Takeaway: In a secondary analysis of 897 adults from the randomized Treatment of Mild Hypertension Study, the alpha-blocker doxazosin raised the odds of blood pressure dropping on standing by about 45%. The common first-line drugs amlodipine and chlorthalidone lowered the long-term rate of that drop. For most patients, standard blood pressure medicine appears to steady the body’s response to standing.

The Dizzy Morning That Changes a Prescription

Picture a 68-year-old retired schoolteacher who gets out of bed, feels the room tilt for a few seconds, and grabs the dresser to stay upright. At her next visit she mentions it almost in passing. Her doctor, mindful that a fall can end an older adult’s independence, cuts back her blood pressure medication. It is one of the most common moves in primary care, and it is often made on instinct rather than evidence.

The medical name for that lightheaded moment is orthostatic hypotension. It means a drop in blood pressure of at least 20 points in the top number, or 10 points in the bottom number, within three minutes of standing[2]. Its less familiar counterpart, orthostatic hypertension, is a spike in blood pressure on standing. Both are signs that the body’s balancing system is struggling, and both become more common with age. Clinicians have long worried that blood pressure pills make the first problem worse. A new look at an older trial suggests that worry is mostly misplaced, with one important exception.

What the Researchers Did

The Treatment of Mild Hypertension Study, or TOMHS, was a randomized, placebo-controlled trial from the late 1980s and early 1990s. All participants received diet and lifestyle counseling. Each was then randomly assigned to placebo or to one of five drugs from different classes, including the diuretic chlorthalidone, the calcium channel blocker amlodipine, and the alpha-blocker doxazosin[3]. Because the drug each person received was decided by chance, the comparisons between drugs are far more trustworthy than those drawn from ordinary prescribing records, where sicker patients tend to receive particular drugs.

In this secondary analysis, investigators went back to standing and seated blood pressure readings from 897 randomized participants. They tracked who developed abnormal postural changes over…

Medically reviewed by

Dr. Şekip Altunkan

Dr. Şekip Altunkan is an internal medicine specialist with extensive clinical experience. He trained at Hacettepe University Faculty of Medicine and later served as an Associate Professor in Internal Medicine. He founded and led the Metropol Internal Medicine and Hypertension Clinic in Ankara, pioneering non-invasive Electron Beam Tomography (EBT) cardiac imaging, arterial-stiffness measurement, and nationwide Holter monitoring. He currently practices at his private clinic in Ankara, focusing on hypertension, vascular health, cholesterol, diabetes and heart disease. He has published widely in national and international journals, serves as a peer reviewer for several international journals, and is the author of the book "Questions and Answers on Hypertension."

Share this article